Skip to content

Enhancing interoceptive awareness in chronic pain and opioid misuse via mindfulness-oriented recovery enhancement.

Anna Parisi, Lisa Taylor-Swanson, Jennifer L. Stewart, Sahib S. Khalsa, Eric L Garland

Drug and Alcohol Dependence June 2, 2025 DOI: 10.1016/j.drugalcdep.2025.112741 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 372
Population Adults with chronic pain on long-term opioid therapy
Intervention Mindfulness-Oriented Recovery Enhancement (MORE)
Duration 8-week intervention, 9-month follow-up
Topics Meditation
Keywords Interoception Interoceptive awareness Opioid misuse treatment Opioid addiction treatment Opioid dependence management Opioid misuse reduction Body awareness Internal sensation perception Visceral perception Mindfulness-based therapy Mindfulness intervention Meditation therapy Awareness training Mindfulness program Chronic pain management Pain relief Chronic pain treatment Pain therapy
Citations 1
Key findings Lower interoceptive awareness was associated with higher opioid misuse at baseline, and a mindfulness-based intervention (MORE) increased interoceptive awareness, which mediated reductions in opioid misuse over nine months.

Abstract

Individuals with substance use disorders often report altered interoceptive awareness of internal bodily signals. However, it is unclear whether these alterations also extend to patients with chronic pain who misuse opioids, and whether interventions that enhance interoceptive awareness, such as mindfulness-based therapies, may reduce opioid misuse in this population. At baseline, participants (N = 372) with chronic pain on long-term opioid therapy completed the Multidimensional Assessment of Interoceptive Awareness (MAIA), Current Opioid Misuse Measure (COMM), and the Brief Pain Inventory. A subset identified as having an elevated risk for opioid misuse (n = 250) were randomized to an 8 week Mindfulness-Oriented Recovery Enhancement (MORE) program or supportive group (SG) psychotherapy, and completed MAIA and COMM ratings through a 9-month follow-up period. At baseline, lower scores on the MAIA Attention Regulation and Trusting subscales were associated with higher levels of opioid misuse, even after accounting for pain severity and interference. MORE led to significantly greater increases in MAIA total and subscale scores (Attention Regulation, Trusting, and others) compared to SG, which mediated its effects on reducing opioid misuse over the 9-month follow-up period. Individuals with chronic pain who misuse opioids report lower interoceptive awareness than those using opioids as prescribed. By increasing interoceptive awareness, mindfulness-based interventions such as MORE may lessen the misuse of opioid analgesic medications. These findings suggest that interoceptive awareness is a promising intervention target for opioid misuse.

Comparable studies

Other randomized controlled trials on meditation, most cited first.

Study Year Design Participants
Alterations in Brain and Immune Function Produced by Mindfulness Meditation Healthy employees in a work environment 2003 Randomized controlled trial n = 41
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Open hearts build lives: Positive emotions, induced through loving-kindness meditation, build consequential personal resources. Working adults 2008 Randomized controlled trial n = 139
Short-term meditation training improves attention and self-regulation Undergraduate Chinese students 2007 Randomized controlled trial n = 40
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Explore topics